Skip to main content

Cardiovascular Outcomes of Treatments available for Patients with Type 1 and 2 Diabetes, An Issue of Endocrinology and Metabolism Clinics of North America

  • 1st book:metaData.edition, common:volume - February 9, 2018
  • book:metaData.latestEdition
  • common:contributors.author Guillermo E. Umpierrez
  • publicationLanguages:language

This issue of Endocrinology and Metabolism Clinics, edited by Dr. Guillermo E. Umpierrez, will focus on Cardiovascular Outcomes of Treatments available for Patients with Type 1 and… seeMoreDescription

promoMetaData.description

This issue of Endocrinology and Metabolism Clinics, edited by Dr. Guillermo E. Umpierrez, will focus on Cardiovascular Outcomes of Treatments available for Patients with Type 1 and 2 Diabetes. Topics include--but are not limited to--Diabetes and CAD and PVD; Prediabetes and CVD- DM prevention; Pathogenesis of atherosclerosis/CVD in diabetes Intensive Diabetes Treatment and CV Outcomes in T1D; Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, Diabetes and Stroke; Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes; Heart Failure in Diabetes Mellitus; Individualizing Glucose Lowering Therapy in the Patient with Diabetes and Heart Disease; Managing Dyslipidemia in Type 2 Diabetes; Blood pressure control and cardiovascular and renal outcomes; Hyperglycemia in acute coronary syndromes; Hospital Glucose Control; Managing Diabetes and cardiovascular risk in chronic kidney disease; and more.

promoMetaData.tableOfContents

Cardiovascular Outcomes of Treatments Available for Patients with Type 1 and 2 Diabetes – Table of Contents

Foreword: Diabetes and Atherosclerotic Cardiovascular Disease

Preface: Diabetes and Atherosclerotic Cardiovascular Disease: Novel Insights and Therapeutic Strategies

The Evolving Epidemiology of Atherosclerotic Cardiovascular Disease in People with Diabetes

Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions

for Prevention and Risk Reduction

Pathogenesis of Cardiovascular Disease in Diabetes

Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes Mellitus: Implications of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study 30-Year Follow-up

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes Mellitus

Cardiovascular Outcomes Trials of Glucose-Lowering Drugs or Strategies in Type 2 Diabetes

Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus

Personalizing Glucose-Lowering Therapy in Patients with Type 2 Diabetes and Cardiovascular Disease

Managing Dyslipidemia in Type 2 Diabetes

Blood Pressure Control and Cardiovascular/Renal Outcomes

Hyperglycemia in Acute Coronary Syndromes: From Mechanisms to Prognostic Implications

Perioperative Management of Hyperglycemia and Diabetes in Cardiac Surgery Patients

Antiplatelet Therapy in Diabetes

Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients

promoMetaData.productDetails

  • productDetails.edition: 1
  • book:metaData.latestEdition
  • productDetails.volume: 47-1
  • productDetails.published: February 9, 2018
  • publicationLanguages:languageTitle: publicationLanguages:en

promoMetaData.aboutTheAuthor

GU

Guillermo E. Umpierrez

promoMetaData.affiliationsAndExpertise
Division of Endocrinology, Lipids, and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA